BBIO — BridgeBio Pharma, Inc. stock price, charts and financials

QT56BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
82.07
+2.11+2.64%
OverviewShort InterestFilings
BBIOQT56BridgeBio Pharma, Inc.·NASDAQ
82.07+2.64%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 03, 20264Statement of changes in beneficial ownership
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 24, 2026S-3ASRS-3ASR
Jul 24, 2026S-8Registration of employee benefit securities
Jul 22, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 10, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 02, 20268-KCurrent report
Jun 26, 20268-KCurrent report
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
#1 / 25 of 492
Page
▼
/ 20